68071-3898-3 : NDC 2026 Code

68071-3898-3 : Ritonavir ( Ritonavir )

Additionally :

You can get information about “68071-3898-3” NDC code in 68071-3898-3 in HTML format

HTML | 68071-3898-3 in TXT (Plain Text) format

TXT | 68071-3898-3 in PDF (Portable Document Format)

PDF | 68071-3898-3 in XML format

XML formats.

NDC Code : 68071-3898-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68071-3898-3",
    "PackageDescription": "3 TABLET, FILM COATED in 1 BOTTLE (68071-3898-3) ",
    "NDC11Code": "68071-3898-03",
    "ProductNDC": "68071-3898",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ritonavir",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ritonavir",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20180917",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA206614",
    "LabelerName": "NuCare Pharmaceuticals, Inc.",
    "SubstanceName": "RITONAVIR",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-09-25",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250924",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}